Phoenix researcher was recently awarded a $1.9 million National Institutes of Health grant to study the molecular mechanisms of how dilated cardiomyopathy progresses to heart failure, which could ...
The RESHAPE-HF2 trial aimed to settle the debate initiated by the conflicting COAPT and MITRA-FR trials, however, it did not clarify the role of transcatheter edge-to-edge repair in heart failure.